- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
Patent holdings for IPC class C12N 15/113
Total number of patents in this class: 26024
10-year publication summary
|
1794
|
1797
|
1972
|
2324
|
2315
|
2635
|
2725
|
2798
|
2708
|
102
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Alnylam Pharmaceuticals, Inc. | 1129 |
690 |
| Ionis Pharmaceuticals, Inc. | 838 |
566 |
| The Regents of the University of California | 19493 |
514 |
| University of Massachusetts | 2190 |
385 |
| Massachusetts Institute of Technology | 9909 |
244 |
| President and Fellows of Harvard College | 5905 |
223 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3353 |
210 |
| Dicerna Pharmaceuticals, Inc. | 287 |
209 |
| Arrowhead Pharmaceuticals, Inc. | 294 |
190 |
| The Broad Institute, Inc. | 1706 |
184 |
| Regeneron Pharmaceuticals, Inc. | 3978 |
182 |
| The General Hospital Corporation | 4642 |
179 |
| Centre National de La Recherche Scientifique | 10068 |
167 |
| Monsanto Technology LLC | 8078 |
156 |
| The Board of Trustees of the Leland Stanford Junior University | 6229 |
155 |
| Sarepta Therapeutics, Inc. | 360 |
147 |
| Hoffmann-La Roche Inc. | 3255 |
144 |
| CuRNA, Inc. | 144 |
129 |
| Board of Regents, The University of Texas System | 5610 |
124 |
| City of Hope | 957 |
120 |
| Other owners | 21106 |